Fluent (TIUM.U.CN) Stock Price

Fluent Price

OTC·CLOSED
0
​
Market closed

Over the last 4 years Fluent grew revenue by 35.9% annually, reaching 97.29 M USD. For Fluent, the net margin of -23.4% is up versus -229.1% a few years ago.

Fluent stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluent business model & stock analysis

Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania.

Frequently asked questions about Fluent

5 analysts currently rate the Fluent stock: 4 recommend buying, 1 holding and 0 selling.

The revenue cannot currently be calculated for Fluent.

The profit cannot currently be calculated for Fluent.

The P/E ratio cannot be calculated for Fluent at the moment.

The P/S cannot be calculated for Fluent currently.

The Eulerpool Quality Score for Fluent is 6/10.

The ISIN of Fluent is CA34380L1022. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Fluent is TIUM.U.CN. The ticker symbol is used to trade Fluent shares on the stock exchange.

Fair ValueTerminal
148.30 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Mar 21, 2019
ISIN
CA34380L1022
Cusip
13809L109
Market capitalization
21.45 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2024
—
P/S
P/Se
—
EV/EBIT
4.71
P/B Ratio
2.50
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-20.66 %
Last updated Nov 5, 2026, 3:22 PM

Fluent Peer Group

Fluent Ticker

OTC · CNTMF

All fundamentals and in-depth analysis of Fluent

Our stock analysis for Fluent stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fluent. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.